Copyright
©The Author(s) 2019.
World J Gastroenterol. Apr 14, 2019; 25(14): 1764-1774
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764
Figure 1 Flow-chart of the study.
CD: Crohn’s Disease; CDEIS: Crohn's Disease Endoscopic Index of Severity; TNF: Tumor necrosis factor.
Figure 2 Endoscopic response and mucosal healing during follow-up.
Figure 3 Receiver operating characteristics curves depicting the endoscopic response at week 14 as a predictor of mucosal healing after one year of anti- tumor necrosis factor treatment.
Area under the curve = 0.778, P = 0.001; ROC: Receiver operating characteristics.
- Citation: Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774
- URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1764